10 Best Performing Mid Cap Stocks to Buy According to Analysts
On February 7, Simeon Hyman, Global Investment Strategist at ProShares Advisors, appeared on CNBC to discuss the upcoming jobs report and its expected impact on the market.
Bridgebio Pharma Inc. (BBIO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 25,120,991 | $689,319,993 | 2.23% | |
| 2. | 140,838,000 | $148,147,492 | 4.39% | ||
| 3. | Farallon Capital Thomas Steyer | 4,195,000 | $115,110,800 | +141% | 0.58% |
| 4. | Laurion Capital Management Benjamin A. Smith | 3,740,896 | $102,650,187 | -4% | 1.87% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,211,521 | $60,684,136 | +133% | 0.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.68 | 1,542 | 3,433 | 2021-12-28 | Filing | ||
| $13.18 | 1,891 | 1,891 | 2021-12-28 | Filing | ||
| $12.68 | 1,542 | 3,433 | 2021-12-28 | Filing | ||
| $13.18 | 1,891 | 1,891 | 2021-12-28 | Filing | ||
| $8.39 | 12,000 | Director | 12,000 | 2022-03-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.58 | 12,875 | 1,764 | 2025-03-06 | Filing | ||
| $32.96 | 6,000,000 | 19,260,971 | 2025-03-05 | Filing | ||
| $34.18 | 100 | 102,464 | 2025-02-25 | Filing | ||
| $33.18 | 8,400 | 102,564 | 2025-02-25 | Filing | ||
| $33.79 | 37,101 | 5,023,447 | 2025-02-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,260,971 | $693,161,044 | 18.56% | |
| 2. | 15,077,915 | $413,737,987 | 0% | |
| 3. | 13,709,646 | $376,192,685 | 0% | |
| 4. | 6,182,627 | $169,651,285 | 0% | |
| 5. | 6,068,125 | $166,509,350 | 59.08% |
News See All
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
10 Unstoppable Stocks to Buy in 2025
As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a strong start.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Healthcare Stocks to Buy Under $50
According to Michael Adams, the Lead Editor of Investing at Forbes, investments in healthcare stocks provide investors with consistent and steady returns because of the defensive nature of these stocks...
14 Best Medical Stocks To Invest In According to Hedge Funds
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...